Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 5 | 2016 | 179 | 0.970 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2017 | 9 | 0.950 |
Why?
|
| Pyridones | 2 | 2017 | 17 | 0.950 |
Why?
|
| Hypnotics and Sedatives | 4 | 2016 | 34 | 0.830 |
Why?
|
| Analgesics | 2 | 2016 | 52 | 0.710 |
Why?
|
| Kidney Diseases | 2 | 2016 | 100 | 0.700 |
Why?
|
| Liver Diseases | 2 | 2016 | 107 | 0.680 |
Why?
|
| Pregnenediones | 1 | 2020 | 1 | 0.660 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2020 | 24 | 0.640 |
Why?
|
| Glucocorticoids | 1 | 2020 | 93 | 0.620 |
Why?
|
| Indoles | 1 | 2017 | 70 | 0.540 |
Why?
|
| Dabigatran | 1 | 2016 | 10 | 0.510 |
Why?
|
| Antithrombins | 1 | 2016 | 9 | 0.510 |
Why?
|
| Blood Coagulation | 1 | 2016 | 30 | 0.500 |
Why?
|
| Hemorrhage | 1 | 2016 | 163 | 0.480 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 114 | 0.470 |
Why?
|
| Nutrition Therapy | 1 | 2014 | 7 | 0.440 |
Why?
|
| Parenteral Nutrition | 1 | 2014 | 19 | 0.430 |
Why?
|
| Critical Care | 5 | 2016 | 199 | 0.430 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 122 | 0.370 |
Why?
|
| Liver Failure | 1 | 2010 | 12 | 0.340 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2008 | 5 | 0.300 |
Why?
|
| Propylene Glycol | 1 | 2008 | 3 | 0.300 |
Why?
|
| Acidosis, Lactic | 1 | 2008 | 5 | 0.300 |
Why?
|
| Enoxaparin | 1 | 2004 | 10 | 0.230 |
Why?
|
| Humans | 15 | 2020 | 40217 | 0.230 |
Why?
|
| Antithrombin III | 1 | 2004 | 14 | 0.230 |
Why?
|
| Burns | 1 | 2004 | 27 | 0.220 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 65 | 0.220 |
Why?
|
| Treatment Outcome | 3 | 2020 | 2863 | 0.200 |
Why?
|
| Kidney Function Tests | 2 | 2016 | 18 | 0.190 |
Why?
|
| Liver Function Tests | 2 | 2016 | 26 | 0.190 |
Why?
|
| Drug Monitoring | 2 | 2016 | 106 | 0.180 |
Why?
|
| Anticoagulants | 2 | 2020 | 328 | 0.160 |
Why?
|
| Medical Order Entry Systems | 1 | 2020 | 35 | 0.160 |
Why?
|
| Electronic Mail | 1 | 2020 | 37 | 0.160 |
Why?
|
| Reminder Systems | 1 | 2020 | 57 | 0.160 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 51 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 107 | 0.150 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 103 | 0.150 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 131 | 0.150 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2017 | 12 | 0.140 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2017 | 12 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 424 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2020 | 238 | 0.140 |
Why?
|
| Diarrhea | 1 | 2017 | 46 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 109 | 0.130 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 270 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 375 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 470 | 0.120 |
Why?
|
| Hospitalization | 1 | 2020 | 729 | 0.120 |
Why?
|
| Quality of Life | 1 | 2020 | 649 | 0.120 |
Why?
|
| Pharmacists | 2 | 2020 | 81 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 452 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 563 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 289 | 0.110 |
Why?
|
| Carnitine | 1 | 2014 | 14 | 0.110 |
Why?
|
| Critical Care Nursing | 1 | 2014 | 9 | 0.110 |
Why?
|
| Selenium | 1 | 2014 | 21 | 0.110 |
Why?
|
| Stroke | 1 | 2020 | 731 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 113 | 0.100 |
Why?
|
| Pharmacokinetics | 1 | 2012 | 4 | 0.100 |
Why?
|
| Lipids | 1 | 2014 | 266 | 0.090 |
Why?
|
| Intensive Care Units | 2 | 2010 | 215 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 2 | 2012 | 35 | 0.080 |
Why?
|
| Insulin | 1 | 2014 | 616 | 0.080 |
Why?
|
| Intestinal Absorption | 2 | 2012 | 24 | 0.080 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 10 | 0.080 |
Why?
|
| Anesthetics, Intravenous | 1 | 2009 | 13 | 0.080 |
Why?
|
| Propofol | 1 | 2009 | 13 | 0.080 |
Why?
|
| Biological Availability | 2 | 2012 | 190 | 0.080 |
Why?
|
| Pentobarbital | 1 | 2008 | 3 | 0.070 |
Why?
|
| Status Epilepticus | 1 | 2008 | 16 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2008 | 89 | 0.070 |
Why?
|
| Female | 6 | 2020 | 20392 | 0.070 |
Why?
|
| Incidence | 1 | 2009 | 773 | 0.070 |
Why?
|
| Telemedicine | 1 | 2010 | 172 | 0.070 |
Why?
|
| Middle Aged | 4 | 2020 | 10090 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 42 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2005 | 36 | 0.060 |
Why?
|
| Half-Life | 1 | 2005 | 60 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 251 | 0.060 |
Why?
|
| Male | 5 | 2020 | 18271 | 0.050 |
Why?
|
| Adult | 3 | 2020 | 10255 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 68 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 243 | 0.040 |
Why?
|
| Home Care Services | 1 | 2020 | 80 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2020 | 160 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 270 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2020 | 203 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 308 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 375 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 552 | 0.030 |
Why?
|
| Massachusetts | 1 | 2020 | 1701 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 2422 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 8182 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 3141 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 63 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2012 | 106 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 68 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 114 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2009 | 77 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2010 | 189 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 170 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1385 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 704 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 408 | 0.020 |
Why?
|
| Heart Failure | 1 | 2009 | 511 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 1958 | 0.010 |
Why?
|